736 results on '"Khoury, Samia J."'
Search Results
102. One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis
103. Reversible neural stem cell niche dysfunction in a model of multiple sclerosis
104. Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis
105. Progressive Multiple Sclerosis
106. Serum vitamin D level is associated with speed of processing in multiple sclerosis patients
107. Development, psychometric properties, and pilot norms of the first Arabic indigenous memory test: The Verbal Memory Arabic Test (VMAT)
108. SARS‐CoV‐2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad
109. “No evidence of disease activity”: Is it an aspirational therapeutic goal in multiple sclerosis?
110. Verbal Memory Arabic Test
111. Multiple sclerosis in the Middle East and North Africa region
112. A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis
113. Rate of Brain Atrophy in Benign vs Early Multiple Sclerosis
114. Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis
115. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
116. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values.
117. Predicting Clinical Progression in Multiple Sclerosis With the Magnetic Resonance Disease Severity Scale
118. Persistent inflammation alters the function of the endogenous brain stem cell compartment
119. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells
120. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing–remitting experimental autoimmune encephalomyelitis
121. Insights Into the Molecular Pathogenesis of Progression in Multiple Sclerosis: Potential Implications for Future Therapies
122. Cytokines in multiple sclerosis: from bench to bedside
123. Kinin B1 Receptor Expression on Multiple Sclerosis Mononuclear Cells: Correlation With Magnetic Resonance Imaging T2-Weighted Lesion Volume and Clinical Disability
124. Multiple Sclerosis
125. Contributors
126. Cyclophosphamide modulates CD4 + T cells into a T helper type 2 phenotype and reverses increased IFN-γ production of CD8 + T cells in secondary progressive multiple sclerosis
127. Assessment by flow cytometry of intracellular cytokine production in the peripheral blood cells of renal transplant recipients
128. The Roles of the New Negative T Cell Costimulatory Pathways in Regulating Autoimmunity
129. Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis
130. Regulatory functions of CD8+CD28− T cells in an autoimmune disease model
131. 20. Immunologic neuromuscular disorders
132. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis
133. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis
134. Surrogate Markers in Multiple Sclerosis
135. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo
136. CD28-independent induction of experimental autoimmune encephalomyelitis
137. Changes in Activated T Cells in the Blood Correlate With Disease Activity in Multiple Sclerosis
138. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo
139. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis
140. List of Contributors
141. Oral Tolerance: A Biologically Relevant Pathway to Generate Peripheral Tolerance against External and Self Antigens (Part 2 of 2)
142. Oral Tolerance: A Biologically Relevant Pathway to Generate Peripheral Tolerance against External and Self Antigens (Part 1 of 2)
143. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities
144. Serum Exosomes from Multiple Sclerosis subjects express EBV-derived proteins and activate Monocyte-Derived Macrophages (P2.2-060)
145. Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents
146. Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance
147. Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
148. Elevated Interleukin-12 in Progressive Multiple Sclerosis Correlates with Disease Activity and Is Normalized by Pulse Cyclophosphamide Therapy
149. Multiple Sclerosis: What Have We Learned From Magnetic Resonance Imaging Studies?
150. Serial Neuropsychological Assessment and Magnetic Resonance Imaging Analysis in Multiple Sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.